Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Giralt

Showing results (111-120 of 176) with videos related to

Pageof 18
Sort By:
Proceedings. Biological Sciences|June 25, 2020
Ecology of the collapse of Rapa Nui societyM Lima, E M Gayo, C Latorre, et al.
Bone Marrow Transplantation|December 6, 2011
Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantationS Avery, M H Voss, A M Gonzales, et al.
Bone Marrow Transplantation|January 10, 2001
Donor leukocyte infusions for multiple myelomaM Salama, T Nevill, D Marcellus, et al.
Bone Marrow Transplantation|June 18, 1999
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemiaD Przepiorka, I Khouri, P Thall, et al.
Bone Marrow Transplantation|August 10, 2000
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)B S Andersson, J Gajewski, M Donato, et al.
Breast Cancer Research and Treatment|August 21, 2001
CK-19 expression by RT-PCR in the peripheral blood of breast cancer patients correlates with response to chemotherapyA R Manhani, R Manhani, H P Soares, et al.
Transplantation|December 27, 1996
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimusD Przepiorka, C Ippoliti, I Khouri, et al.
Bone Marrow Transplantation|January 5, 2016
Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis studyS Afifi, N G Adel, S Devlin, et al.
Blood|December 23, 1999
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host diseaseD Przepiorka, N A Kernan, C Ippoliti, et al.
Blood Cancer Journal|September 18, 2012
Cancer-testis antigen expression and immunogenicity in AL amyloidosisM A Rosenzweig, H Landau, D Seldin, et al.
Pageof 18

Showing results (111-120 of 176) with videos related to

Sort By:
Pageof 18
Proceedings. Biological Sciences|June 25, 2020
Ecology of the collapse of Rapa Nui societyM Lima, E M Gayo, C Latorre, et al.
Bone Marrow Transplantation|December 6, 2011
Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantationS Avery, M H Voss, A M Gonzales, et al.
Bone Marrow Transplantation|January 10, 2001
Donor leukocyte infusions for multiple myelomaM Salama, T Nevill, D Marcellus, et al.
Bone Marrow Transplantation|June 18, 1999
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemiaD Przepiorka, I Khouri, P Thall, et al.
Bone Marrow Transplantation|August 10, 2000
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)B S Andersson, J Gajewski, M Donato, et al.
Breast Cancer Research and Treatment|August 21, 2001
CK-19 expression by RT-PCR in the peripheral blood of breast cancer patients correlates with response to chemotherapyA R Manhani, R Manhani, H P Soares, et al.
Transplantation|December 27, 1996
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimusD Przepiorka, C Ippoliti, I Khouri, et al.
Bone Marrow Transplantation|January 5, 2016
Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis studyS Afifi, N G Adel, S Devlin, et al.
Blood|December 23, 1999
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host diseaseD Przepiorka, N A Kernan, C Ippoliti, et al.
Blood Cancer Journal|September 18, 2012
Cancer-testis antigen expression and immunogenicity in AL amyloidosisM A Rosenzweig, H Landau, D Seldin, et al.
Pageof 18